Clinical Trials Browser

INDUSTRY × Uveal Melanoma × trametinib × Clear all

NCT01328106 2017-12-12

Efficacy and Safety Study of GSK1120212, a MEK Inhibitor, in Subjects With Uveal Melanoma

Phase 2 Withdrawn

Uveal Melanoma, Neoplasms